Clinovo supports Medidata Rave®, the current industry leading Electronic Data Capture and Clinical Data Management System. Clinovo is able to tailor the Rave EDC system through custom functions and implement sophisticated eCRF designs to meet your specific clinical study protocol requirements. Our unique clinical trial technology expertise, combined with our strong clinical data management background, make us the partner a choice for EDC management with the Medidata Rave EDC system.
 

With Clinovo, you get:

 

 
  • Improved clinical data accuracy, completeness and integrity
  • Faster clinical study build in Medidata Rave
  • 21 CFR Part 11 compliance
  • Sophisticated edit checks customized to your needs
  • Increased design flexibility of eCRFs
  • Real time access to clinical data


Click here to contact our sales team and find out how we can help you increase the performance of your clinical trial!


Our Electronica Data Capture team and our Medidata Rave certified experts deliver the following services on the Mediata Rave EDC platform:

  • Clinical study build
  • Configuration of User Interface (UI) and workflow
  • eCRF design
  • Controlled access to eCRFs/data entry
  • Clinical system validation
  • Complex edit checks configuration and verification
  • Custom functions development
  • User acceptance testing (UAT)
  • Global library set-up with standard architect elements

 

 

 

Clinovo’s EDC expertise

Our Electronic Data Management team is experienced in designing, building, and conducting studies using leading EDC systems, including Medidata Rave®OpenClinica™ and Oracle™ Remote Data Capture (RDC). Leveraging our unmatched technology and IT knowledge, we streamline your Electronic Data Capture process and help you increase the performance of your clinical trial.Our certified EDC experts can implement and customize roles, workflows, and eCRF features for any clinical study, no matter its complexity, to help you avoid human error during clinical data collection and assess your clinical data quality at an earlier clinical trial stage. Read more